{"abstract": "The delay comes as concerns mount about the safety of drugs in its class and provides a temporary reprieve to rival Amgen. ", "web_url": "https://www.nytimes.com/2007/05/19/business/19anemia.html", "snippet": "The delay comes as concerns mount about the safety of drugs in its class and provides a temporary reprieve to rival Amgen. ", "lead_paragraph": "The Food and Drug Administration has delayed approval of Roche\u2019s new anemia drug, as concerns mount about the safety of drugs in its class. ", "print_section": "C", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Is Delaying Approval of Anemia Drug From Roche", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Is Delaying Approval Of Anemia Drug From Roche", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "ANEMIA", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Roche Holding Ltd", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 5, "major": "N"}], "pub_date": "2007-05-19T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/f904779c-a94a-564f-8b5f-c213916020f2", "word_count": 755, "uri": "nyt://article/f904779c-a94a-564f-8b5f-c213916020f2"}